BioNTech SE (BNTX) Net Cash Flow (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Net Cash Flow data on file, last reported at -$2.8 billion in Q4 2025.

• In Q4 2025, Net Cash Flow fell 2045.25% year-over-year to -$2.8 billion; the TTM figure through Dec 2025 stood at -$3.7 billion (down 162.27% YoY), while the FY2025 annual figure was -$2.3 billion, down 13.77% from the prior year.
• Net Cash Flow slipped to -$2.8 billion in Q4 2025, from -$13.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $4.2 billion in Q3 2022 and bottomed at -$2.9 billion in Q1 2024.
• A 5-year average of $168.4 million and a median of $38.3 million in 2022 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2022 — Net Cash Flow surged 928.72% — and 2023, when it sank 2129.52%.
• Year by year, Net Cash Flow stood at -$113.9 million in 2021, then surged by 928.72% to $944.2 million in 2022, then slumped by 311.61% to -$2.0 billion in 2023, then jumped by 107.28% to $145.4 million in 2024, then tumbled by 2045.25% to -$2.8 billion in 2025.
• The last three Net Cash Flow figures came in at -$2.8 billion (Q4 2025), -$13.4 million (Q3 2025), and -$15.1 million (Q2 2025), per Business Quant data.

Peer Comparison